lidocaine 5% / Generic mfg. 
Welcome,         Profile    Billing    Logout  
 53 Diseases   10 Trials   10 Trials   361 News 


«123»
  • ||||||||||  lidocaine topical / Generic mfg., lidocaine 5% / Generic mfg.
    Trial initiation date:  EASY: Pre-emptive Topical Lidocaine 5% Plaster for Prevention of Post-craniotomy Pain (clinicaltrials.gov) -  Mar 10, 2020   
    P3,  N=180, Not yet recruiting, 
    Adjunctive lidocaine 5% patches did not reduce acute pain in postthoracotomy and post-sternotomy patients in the cardiothoracic intensive care unit. Initiation date: Jan 2021 --> Jun 2020
  • ||||||||||  lidocaine topical / Generic mfg., Botox (onabotulinumtoxin A) / GSK, Allergan
    Journal:  Long-term effectiveness of topical analgesics (Pubmed Central) -  Feb 25, 2020   
    Initiation date: Jan 2021 --> Jun 2020 Despite the long duration of the disease, the most used off-label topical drugs L and B demonstrated a high primary response rate (in contrast to C), with most benefiting from long-term treatment.
  • ||||||||||  lidocaine topical / Generic mfg., lidocaine 5% / Generic mfg.
    Trial completion date, Trial initiation date, Trial primary completion date:  EASY: Pre-emptive Topical Lidocaine 5% Plaster for Prevention of Post-craniotomy Pain (clinicaltrials.gov) -  Feb 18, 2020   
    P3,  N=180, Not yet recruiting, 
    Despite the long duration of the disease, the most used off-label topical drugs L and B demonstrated a high primary response rate (in contrast to C), with most benefiting from long-term treatment. Trial completion date: Jan 2022 --> Jan 2023 | Initiation date: Jan 2020 --> Jan 2021 | Trial primary completion date: Jan 2022 --> Jan 2023
  • ||||||||||  Journal:  Eslicarbazepine acetate for neuropathic pain, headache, and cranial neuralgia: Evidence and experience. (Pubmed Central) -  Jan 30, 2020   
    Evidence is insufficient to recommend ESL for neuropathic pain, headache, and cranial neuralgia. Most of the available evidence comes from open and observational studies with small sample sizes and no control group; however, their favourable results call for further studies on the usefulness of ESL for neuropathic pain, headache, and cranial neuralgia.
  • ||||||||||  lidocaine topical / Generic mfg.
    Trial completion date, Trial primary completion date:  Pharmacokinetics of Lidocaine in Healthy Adults (clinicaltrials.gov) -  Dec 20, 2019   
    P4,  N=23, Active, not recruiting, 
    Both acupuncture techniques showed a favorable effect; however, the contribution to pain relief is undetermined. Trial completion date: Dec 2019 --> Dec 2020 | Trial primary completion date: Oct 2019 --> Oct 2020
  • ||||||||||  lidocaine 5% / generics
    Journal:  Lidocaine 5% Patch in Localized Neuropathic Pain. (Pubmed Central) -  Nov 3, 2019   
    Trial completion date: Dec 2019 --> Dec 2020 | Trial primary completion date: Oct 2019 --> Oct 2020 No abstract available
  • ||||||||||  Exparel (bupivacaine liposome injectable suspension) / Pacira
    Review, Journal:  Local Anesthetics: Pharmacology and Special Preparations. (Pubmed Central) -  Nov 2, 2019   
    The clinical use, such intravenous administration of lidocaine, and local and systemic toxic effects are covered. A review of current studies published in the human and veterinary literature on lidocaine patches (Lidoderm) and liposomal bupivacaine (Experal and Nocita) are discussed.
  • ||||||||||  lidocaine topical / Generic mfg.
    Enrollment closed:  Pharmacokinetics of Lidocaine in Healthy Adults (clinicaltrials.gov) -  Oct 22, 2019   
    P4,  N=23, Active, not recruiting, 
    A review of current studies published in the human and veterinary literature on lidocaine patches (Lidoderm) and liposomal bupivacaine (Experal and Nocita) are discussed. Recruiting --> Active, not recruiting
  • ||||||||||  lidocaine 5% / Generic mfg.
    Enrollment open, Trial primary completion date:  Intralipid (clinicaltrials.gov) -  Jul 31, 2019   
    P4,  N=18, Enrolling by invitation, 
    Recruiting --> Completed | N=45 --> 4575 | Trial completion date: Jul 2020 --> Sep 2019 Not yet recruiting --> Enrolling by invitation | Trial primary completion date: Jun 2020 --> Sep 2020
  • ||||||||||  lidocaine topical / Generic mfg.
    Trial completion, Trial completion date:  Post-Op Lidocaine Patch (clinicaltrials.gov) -  Jun 4, 2019   
    P4,  N=50, Completed, 
    Not yet recruiting --> Enrolling by invitation | Trial primary completion date: Jun 2020 --> Sep 2020 Recruiting --> Completed | Trial completion date: Jun 2019 --> Mar 2019
  • ||||||||||  lidocaine 5% / Generic mfg.
    New P4 trial:  Intralipid (clinicaltrials.gov) -  May 29, 2019   
    P4,  N=18, Not yet recruiting, 
  • ||||||||||  lidocaine topical / Generic mfg.
    Trial completion date, Trial primary completion date:  Pharmacokinetics of Lidocaine in Healthy Adults (clinicaltrials.gov) -  Apr 16, 2019   
    P4,  N=24, Recruiting, 
    No abstract available Trial completion date: Dec 2018 --> Dec 2019 | Trial primary completion date: Dec 2018 --> Oct 2019
  • ||||||||||  Avastin (bevacizumab) / Roche, Lucentis (ranibizumab) / Roche, Novartis
    Journal:  Lid splinting eyelid retraction technique: a minimised sterile approach for intravitreal injections. (Pubmed Central) -  Mar 29, 2019   
    This is beneficial for both the physician and the patient as it minimises patient discomfort as well as the duration of the procedure. To our knowledge, this is one of the largest studies performed to date evaluating intravitreal injection-related endophthalmitis.
  • ||||||||||  lidocaine 5% / Generic mfg.
    Trial completion date, Trial primary completion date:  Adjunctive 5% Lidocaine Patches for Acute Non-radicular Low Back Pain in Emergency Department Patients (clinicaltrials.gov) -  Mar 1, 2019   
    P4,  N=100, Recruiting, 
    To our knowledge, this is one of the largest studies performed to date evaluating intravitreal injection-related endophthalmitis. Trial completion date: Nov 2018 --> Jul 2020 | Trial primary completion date: Oct 2018 --> Jun 2020
  • ||||||||||  lidocaine topical / Generic mfg.
    New P4 trial:  Post-Op Lidocaine Patch (clinicaltrials.gov) -  Apr 18, 2018   
    P4,  N=50, Recruiting, 
  • ||||||||||  lidocaine topical / Generic mfg.
    Enrollment open, Trial initiation date:  Pharmacokinetics of Lidocaine in Healthy Adults (clinicaltrials.gov) -  Mar 21, 2018   
    P4,  N=24, Recruiting, 
    Trial completion date: Dec 2019 --> Mar 2020 | Trial primary completion date: Dec 2018 --> Mar 2019 Not yet recruiting --> Recruiting | Initiation date: Nov 2017 --> Mar 2018
  • ||||||||||  lidocaine 5% / Generic mfg.
    Enrollment open, Trial completion date, Trial primary completion date:  Lidoderm Patch (Lidocaine 5%) for Tinnitus Treatment (clinicaltrials.gov) -  Feb 28, 2018   
    P4,  N=58, Recruiting, 
    Not yet recruiting --> Recruiting | Initiation date: Oct 2017 --> Jan 2018 Not yet recruiting --> Recruiting | Trial primary completion date: Jan 2017 --> Feb 2019 | Trial completion date: Apr 2017 --> Feb 2019
  • ||||||||||  lidocaine 5% / Generic mfg.
    Enrollment change, Trial withdrawal:  TDS_TSG_DI: Standard TDS Irritation Study: Trained Skin Grader vs. Digital Imaging (clinicaltrials.gov) -  Oct 9, 2017   
    P=N/A,  N=0, Withdrawn, 
    Not yet recruiting --> Recruiting | Trial primary completion date: Jan 2017 --> Feb 2019 | Trial completion date: Apr 2017 --> Feb 2019 N=38 --> 0 | Not yet recruiting --> Withdrawn
  • ||||||||||  lidocaine 5% / Generic mfg.
    Trial completion, Grant:  The Effect of Intravenous Lidocaine on Allodynia (clinicaltrials.gov) -  Sep 15, 2016   
    P=N/A,  N=10, Completed, 
    No abstract available Active, not recruiting --> Completed
  • ||||||||||  lidocaine 5% / Generic mfg.
    Trial completion, Enrollment change, Trial primary completion date:  Commercial Lidocaine Patch as a Treatment for Ear-ringing (clinicaltrials.gov) -  Feb 26, 2016   
    P0,  N=30, Completed, 
    Recruiting --> Active, not recruiting | N=600 --> 444 Recruiting --> Completed | N=44 --> 30 | Trial primary completion date: Dec 2014 --> Aug 2015